Beijing Strong BiotechnologiesInc Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Hongjun Liang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.7yrs |
| CEO ownership | n/a |
| Management average tenure | 9.9yrs |
| Board average tenure | 8.1yrs |
Recent management updates
Recent updates
Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock Rockets 27% But Many Are Still Ignoring The Company
Feb 19
Beijing Strong BiotechnologiesInc (SZSE:300406) Could Easily Take On More Debt
Jan 01Cautious Investors Not Rewarding Beijing Strong Biotechnologies,Inc.'s (SZSE:300406) Performance Completely
Dec 02Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?
Jul 25Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price
Jul 03An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued
Jun 14Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?
Mar 21Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified
Mar 03Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)
Feb 27CEO
Hongjun Liang (49 yo)
Mr. Hongjun Liang is Non-Independent Director & Vice Chairman of Beijing Strong Biotechnologies,Inc. from August 13, 2020 and has been its General Manager since September 22, 2023.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Vice Chairman | 1.7yrs | no data | no data | |
| CFO & Accounting Supervisor | 14.2yrs | CN¥620.40k | 0.027% CN¥ 2.1m | |
| Secretary of the Board of Directors | 9.9yrs | CN¥1.29m | 0.071% CN¥ 5.7m | |
| Deputy General Manager | no data | CN¥966.30k | 0.061% CN¥ 4.9m | |
| Deputy General Manager | no data | CN¥1.60m | 0.048% CN¥ 3.8m | |
| Deputy General Manager | no data | CN¥2.04m | 0.054% CN¥ 4.3m |
Experienced Management: 300406's management team is seasoned and experienced (9.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Vice Chairman | 4.8yrs | no data | no data | |
| Chairman of the Board | 14.2yrs | CN¥2.80m | 6.73% CN¥ 533.0m | |
| Non-Independent Director | 14.2yrs | no data | 8.64% CN¥ 683.8m | |
| Non-Independent Director | 14.2yrs | no data | 9.76% CN¥ 773.2m | |
| Non-Independent Director | 14.2yrs | CN¥2.12m | 11.48% CN¥ 909.4m | |
| Chairman of the Supervisory Committee | 8.1yrs | CN¥84.00k | no data | |
| Independent Director | 4.8yrs | CN¥84.00k | no data | |
| Employee Supervisor | 8.8yrs | no data | no data | |
| Non-Independent Director | 1.7yrs | CN¥3.05m | 0.080% CN¥ 6.3m | |
| Independent Director | 1.7yrs | CN¥84.00k | no data | |
| Independent Director | 1.7yrs | CN¥84.00k | no data |
Experienced Board: 300406's board of directors are considered experienced (8.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 16:27 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Strong Biotechnologies,Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Mingrui Wang | Everbright Securities Co. Ltd. |
| Xiangyang Du | Industrial Securities Co. Ltd. |